Aptose Biosciences Inc. (APS) Fundamentals

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. Luxeptinib, its panFMS-like tyrosine kinase 3 / pan-Bruton's tyrosine kinase inhibitor, is enrolling patients in a Phase 1, multicenter, open label, dose-escalation study with expansions to assess the safety, tolerability, PK, and preliminary efficacy of CG-806 in patients with chronic lymphocytic leukemia (CLL/SLL) or non-Hodgkin lymphomas (NHL). HM43239 is an oral potent myeloid kinome inhibitor, targeting a constellation of kinases operative in myeloid malignancies.
SHARE INFORMATION
Market Cap$ 87.617.730
Shares Outstanding92.253.703
Float90.978.701
Percent Float98,64%
Short Interest814.915,00
Short Percent Float100,0%
Short Interest Ratio25,7185
Short Interest Date2022-06-15
Latest Fiscal Dividend Per Share$ 0,00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0,92
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0,00
Dividend (5 Years)$ 0,00
Ex Dividend Date-
Dividend Rate$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions98
Institutional Holdings Date2022-05-31
Institutional Bought Previous 3 Months1.028.362
Institutional Holdings Percent32,0%
Institutional Sold Previous 3 Months1.523.886
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months-
Insider Holdings Percent1,3
Insider Sold Previous 3 Months-
Insider Shares Owned31.995.109
TRADING INFO
52 Week High$ 4,30
52 Week Low$ 0,95
52 Week High Change$ -76,83
21 Day Moving Average$ 1,1167
21 Day Extended Moving Average$ 1,1154
50 Day Moving Average$ 1,2734
50 Day Extended Moving Average$ 1,2475
200 Day Moving Average$ 1,9371
200 Day Extended Moving Average$ 2,0913
10 Day Average Volume15.921
20 Day Average Volume18.774
30 Day Average Volume18.554
50 Day Average Volume20.958
Alpha0.013745
Beta1.250148
Standard Deviation0.227223
R20.050199
7 Day Price Change$ -0,13
7 Day Percent Change-12,04%
21 Day Price Change$ -0,22
21 Day Percent Change-18,8%
30 Day Price Change$ -0,34
30 Day Percent Change-26,36%
Month to Date Price Change$ -0,34
Month to Date Percent Change-26,36%
Quarter to Date Price Change$ -0,75
Quarter to Date Percent Change-44,12%
180 Day Price Change$ -0,78
180 Day Percent Change-45,09%
200 Day Price Change$ -1,59
200 Day Percent Change-62,6%
Year to Date Price Change$ -0,78
Year to Date Percent Change-45,09%

Aptose Biosciences Inc. (APS) Key Ratios

PROFITABILITY
EBIT Margin0,0%
EBITDA Margin0,0%
Pre-Tax Profit Margin0,0%
Profit Margin Count0,0%
Gross Margin0,0%
Profit Margin TOT0,0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0,00
Revenue (3 Years)$ 0,00
Revenue (5 Years)$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book1,15
Total Debt To Equity0,01
Int Coverage0,00
Current Ratio9,80
Leverage Ratio1,10
Quick Ratio9,50
Long Term Debt To Capital0,00
VALUATION MEASURES
PE Ratio-1,20
Enterprise Value$ 5.248.134
Price to Sales0,00
Price to Free Cash-2,20
PE High Last 5 Years-2,10
Price To Book1,12
Price To Cash Flow0,00
PE Low Last 5 Years-7,40
Price to Tangible Book1,15
MANAGEMENT EFFECTIVENESS
Receivables Turnover0,00
Invoice Turnover0,00
Assets Turnover0,00
Return Assets-64,35
Return on Equity-69,17
Return on Capital-68,91

Aptose Biosciences Inc. (APS) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEOWilliam G. Rice
Emplyoees41
Last AuditUQ
CIK0000882361
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address251 Consumers Road
Suite 1105
Toronto, ON M2J 4R3
Websitehttps://www.aptose.com
Facsimile-
Telephone+1 650 718-5028
Emailir@aptose.com
Kürzlich von Ihnen besucht
TSX
APS
Aptose Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Der Markt LS (Lang&Schwarz) wird als Realtime Indikation kostenlos angezeigt und bietet Ihnen außerbörsliche Realtime Aktienkurse in der Zeit von Mo-Fr 08:00 bis 23:00, Samstags 10:00 bis 13:00 und Sonntags an.
NYSE und AMEX Kurse sind um mindestens 20 Minuten zeitverzögert.
Alle weiteren Kurse sind um mindestens 15 Minuten zeitverzögert, sofern nicht anders angegeben.

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V:de D:20220701 19:19:20